Decellularized human-sized pulmonary scaffolds for lung tissue engineering: a comprehensive review
Abstract
The ultimate goal of lung bioengineering is to produce transplantable lungs for human beings. Therefore, large-scale studies are of high importance. In this paper, we review the investigations on decellularization and recellularization of human-sized lung scaffolds. First, studies that introduce new ways to enhance the decellularization of large-scale lungs are reviewed, followed by the investigations on the xenogeneic sources of lung scaffolds. Then, decellularization and recellularization of diseased lung scaffolds are discussed to assess their usefulness for tissue engineering applications. Next, the use of stem cells in recellularizing acellular lung scaffolds is reviewed, followed by the case studies on the transplantation of bioengineered lungs. Finally, the remaining challenges are discussed, and future directions are highlighted.
Graphical abstract
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Evaluation and management of the potential lung donor. Clin. Chest Med. 38(4), 751–759 (2017).
- 2. . Overview of clinical lung transplantation. Cold Spring Harb. Perspect. Med. 4(1), a015628–a015628 (2014).
- 3. . Rising to the challenge of unmet need: expanding the lung donor pool. Curr. Pulmonol. Reports 7(3), 92–100 (2018).
- 4. . Combination therapy for airflow limitation in COPD. DARU, J. Pharm. Sci. 20(1), 6 (2012).
- 5. High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury. Eur. J. Clin. Pharmacol. 73(5), 573–580 (2017).
- 6. The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation. Am. J. Transplant. 20(1), 241–249 (2020).
- 7. . 3D bioprinting for lung and tracheal tissue engineering: criteria, advances, challenges, and future directions. Bioprinting 21(4), e00124 (2021).
- 8. . Opportunities and challenges of translational 3D bioprinting. Nat. Biomed. Eng. 4(4), 370–380 (2020).
- 9. . Lung tissue bioengineering for chronic obstructive pulmonary disease: overcoming the need for lung transplantation from human donors. Expert Rev. Respir. Med. 13(7), 665–678 (2019).
- 10. . How to build a lung: latest advances and emerging themes in lung bioengineering. Eur. Respir. J. 52(1), 1601355 (2018).
- 11. . Strategies for whole lung tissue engineering. IEEE Trans. Biomed. Eng. 61(5), 1482–1496 (2014).
- 12. . Recent advances in biomaterials for 3D scaffolds: a review. Bioact. Mater. 4, 271–292 (2019).
- 13. . Challenges with the development of biomaterials for sustainable tissue engineering. Front. Bioeng. Biotechnol. 7(1), 127 (2019).
- 14. . Preparation and composition of alveolar extracellular matrix and incorporated basement membrane. Lung 159(1), 333–345 (1981).
- 15. . Repopulation of a human alveolar matrix by adult rat type II pneumocytes in vitro. A novel system for type II pneumocyte culture. Exp. Cell Res. 162(2), 423–435 (1986).
- 16. . Development of a decellularized lung bioreactor system for bioengineering the lung: the matrix reloaded. Tissue Eng. – Part A 16(8), 2581–2591 (2010).
- 17. Tissue-engineered lungs for in vivo implantation. Science 329(5991), 538–541 (2010). • It and the following one are the pioneer studies in lung tissue engineering, both of which transplanted the engineered lung into rats. This study also performed the first human lung decellularization.
- 18. Regeneration and orthotopic transplantation of a bioartificial lung. Nat. Med. 16(8), 927–933 (2010). • The bioengineered lungs of this study participated in gas exchange for up to 6 h when transplanted in rat models.
- 19. Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng. - Part A 16(8), 2565–2580 (2010).
- 20. Nonhuman primate lung decellularization and recellularization using a specialized large-organ bioreactor. J. Vis. Exp. (82), 1–11 (2013).
- 21. Regenerative potential of human airway stem cells in lung epithelial engineering. Biomaterials 108, 111–119 (2016).
- 22. Re-endothelialization of rat lung scaffolds through passive, gravity-driven seeding of segment-specific pulmonary endothelial cells. J. Tissue Eng. Regen. Med. 12(2), e786–e806 (2018).
- 23. . Advances in bioreactors for lung bioengineering: from scalable cell culture to tissue growth monitoring. Biotechnol. Bioeng. 118(6), 2142–2167 (2021).
- 24. . Recellularization on acellular lung tissue scaffold using perfusion-based bioreactor: an online monitoring strategy. J. Med. Biol. Eng. 37(1), 53–62 (2017).
- 25. Automated decellularization of intact, human-sized lungs for tissue engineering. 21(1), 94–103 (2015).
- 26. Biomimetic culture reactor for whole-lung engineering. Biores. Open Access 5(1), 72–83 (2016).
- 27. . Controlled gas exchange in whole lung bioreactors. J. Tissue Eng. Regen. Med. 12(1), e119–e129 (2018).
- 28. Rapid porcine lung decellularization using a novel organ regenerative control acquisition bioreactor. ASAIO J. 61(1), 71–77 (2015).
- 29. . Noninvasive real-time assessment of cell viability in a three-dimensional tissue. Tissue Eng. – Part C Methods 24(4), 197–204 (2018). • Introduced an online, real-time and noninvasive monitoring bioreactor for assessment of recellularized lung tissue growth.
- 30. . Bioreactor for the long-term culture of lung tissue. Cell Transplant. 20(7), 1117–1126 (2011).
- 31. . A rotating bioreactor for scalable culture and differentiation of respiratory epithelium. Cell Med. 7(3), 109–121 (2015).
- 32. A nonhuman primate model of lung regeneration: detergent-mediated decellularization and initial in vitro recellularization with mesenchymal stem cells. Tissue Eng. - Part A 18(23–24), 2437–2452 (2012).
- 33. Production and assessment of decellularized pig and human lung scaffolds. Tissue Eng. - Part A 19(17–18), 2045–2062 (2013).
- 34. Enhanced lung epithelial specification of human induced pluripotent stem cells on decellularized lung matrix. Ann. Thorac. Surg. 98(5), 1721–1729 (2014).
- 35. Development and characterization of a naturally derived lung extracellular matrix hydrogel. J. Biomed. Mater. Res. - Part A 104(8), 1922–1935 (2016).
- 36. Comparative biology of decellularized lung matrix: implications of species mismatch in regenerative medicine. Biomaterials 102, 220–230 (2016).
- 37. Giving new life to old lungs: methods to produce and assess whole human paediatric bioengineered lungs. J. Tissue Eng. Regen. Med. 11(7), 2136–2152 (2017).
- 38. Bioengineering human lung grafts on porcine matrix. Ann. Surg. 267(3), 590–598 (2018). •• Proved the feasibility of engineering and transplantation of viable lung grafts based on decellularized porcine lung scaffolds and human endothelial and epithelial cells.
- 39. Production and transplantation of bioengineered lung into a large-animal model. Sci. Transl. Med. 10(452), eaao3926 (2018). •• Long-term survival of recellularized porcine lungs following transplantation.
- 40. . A fully automated high-throughput bioreactor system for lung regeneration. Tissue Eng. – Part C Methods 24(11), 671–678 (2018). • Designed an automated multichannel bioreactor able to monitor and optimize many parameters of the culture media for rodent-scale isolated lung culture to promote lung bioengineering.
- 41. Residual detergent detection method for nondestructive cytocompatibility evaluation of decellularized whole lung scaffolds. Tissue Eng. – Part C Methods 22(5), 418–428 (2016).
- 42. Decellularization of human and porcine lung tissues for pulmonary tissue engineering. Ann. Thorac. Surg. 96(3), 1046–1056 (2013).
- 43. Fibrillin-2 and Tenascin-C bridge the age gap in lung epithelial regeneration. Biomaterials 140, 212–219 (2017).
- 44. Vacuum-assisted decellularization: an accelerated protocol to generate tissue-engineered human tracheal scaffolds. Biomaterials 124, 95–105 (2017).
- 45. Three-dimensional scaffolds of acellular human and porcine lungs for high throughput studies of lung disease and regeneration. Biomaterials 35(9), 2664–2679 (2014).
- 46. . Decellularized extracellular matrix: a step towards the next generation source for bioink manufacturing. Biofabrication 9(3), 034104 (2017).
- 47. . An overview of tissue and whole organ decellularization processes. Biomaterials 32(12), 3233–3243 (2011).
- 48. Novel method of decellularization of porcine valves using polyethylene glycol and gamma irradiation. Ann. Thorac. Surg. 83(4), 1501–1507 (2007).
- 49. . Decellularized human cornea for reconstructing the corneal epithelium and anterior stroma. Tissue Eng. – Part C Methods 18(5), 340–348 (2012).
- 50. . Perfusion decellularization of whole organs. Nat. Protoc. 9(6), 1451–1468 (2014).
- 51. . Repopulation of decellularized whole organ scaffold using stem cells: an emerging technology for the development of neo-organ. J. Artif. Organs 17(4), 291–300 (2014).
- 52. . Decellularization of tissues and organs. Biomaterials 27(19), 3675–3683 (2006).
- 53. Method of isolated ex vivo lung perfusion in a rat model: lessons learned from developing a rat EVLP program. J. Vis. Exp. 96(1), e52309 (2015).
- 54. . Large animal model efficacy testing is needed prior to launch of a stem cell clinical trial: an evidence-lacking conclusion based on conjecture. Circ. Res. 121(5), 496–498 (2017).
- 55. . Animal models in translational medicine: validation and prediction. New Horizons Transl. Med. 2(1), 5–11 (2014).
- 56. Perfusion-decellularization of porcine lung and trachea for respiratory bioengineering. Artif. Organs 39(12), 1024–1032 (2015).
- 57. Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am. J. Respir. Crit. Care Med. 186(9), 866–876 (2012).
- 58. Perfusion decellularization of human and porcine lungs: bringing the matrix to clinical scale. J. Hear. Lung Transplant. 33(3), 298–308 (2014).
- 59. . Bioengineering lungs for transplantation. Thorac. Surg. Clin. 26(2), 163–171 (2016).
- 60. Servier Laboratories. Servier Medical Arts (2020). https://smart.servier.com/
- 61. Design and synthesis of an artificial pulmonary pleura for high throughput studies in acellular human lungs. Cell. Mol. Bioeng. 7(2), 184–195 (2014).
- 62. Production of decellularized porcine lung scaffolds for use in tissue engineering. Integr. Biol. (Camb) 7(12), 1598–1610 (2015).
- 63. Comparative decellularization and recellularization of wild-type and alpha 1,3 galactosyltransferase knockout pig lungs: a model for ex vivo xenogeneic lung bioengineering and transplantation. Tissue Eng. – Part C Methods 22(8), 725–739 (2016).
- 64. . Summary health statistics for U.S. adults: national health interview survey, 2012. Vital Health Stat. 10(260), 1–161 (2014).
- 65. A global view of pulmonary hypertension. Lancet Respir. Med. 4(4), 306–322 (2016).
- 66. The etiologic origins for chronic obstructive pulmonary disease. Int. J. COPD 14, 1139–1158 (2019).
- 67. Comparative decellularization and recellularization of normal versus emphysematous human lungs. Biomaterials 35(10), 3281–3297 (2014).
- 68. Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in mammalian lung fibrosis. Sci. Transl. Med. 6(240), 240ra76–240ra76 (2014).
- 69. Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J. Clin. Invest. 124(4), 1622–1635 (2014).
- 70. Human pericytes adopt myofibroblast properties in the microenvironment of the IPF lung. JCI Insight 2(24), 1–13 (2017).
- 71. Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis. DMM Dis. Model. Mech. 10(11), 1301–1312 (2017).
- 72. TGF-β1-induced deposition of provisional extracellular matrix by tracheal basal cells promotes epithelial-to-mesenchymal transition in a c-Jun NH2-terminal kinase-1-dependent manner. Am. J. Physiol. – Lung Cell. Mol. Physiol. 314(6), L984–L997 (2018).
- 73. Bronchial extracellular matrix from COPD patients induces altered gene expression in repopulated primary human bronchial epithelial cells. Sci. Rep. 8(1), 1–13 (2018).
- 74. et al. Netrin-1 regulates fibrocyte accumulation in the decellularized fibrotic scleroderma lung microenvironment and in bleomycin induced pulmonary fibrosis. Arthritis Rheumatol. 68(5), 1251–1261 (2016).
- 75. Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix. J. Clin. Invest. 123(11), 4950–4962 (2013).
- 76. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat. Biotechnol. 32(1), 84–91 (2014).
- 77. . Alveolar epithelial differentiation of human induced pluripotent stem cells in a rotating bioreactor. Biomaterials 35(2), 699–710 (2014).
- 78. . Epithelial cell differentiation of human mesenchymal stromal cells in decellularized lung scaffolds. Tissue Eng. – Part A 20(11–12), 1735–1746 (2014).
- 79. Bioengineered lungs generated from human iPSCs-derived epithelial cells on native extracellular matrix. J. Tissue Eng. Regen. Med. 12(3), e1623–e1635 (2018).
- 80. . Tissue Specificity of decellularized rhesus monkey kidney and lung scaffolds. PLoS ONE 8(5), e64134 (2013).
- 81. . Tissue-specific contribution of macrophages to wound healing. Semin. Cell Dev. Biol. 61, 3–11 (2017).
- 82. . Mesenchymal stromal cells: a novel therapy for the treatment of chronic obstructive pulmonary disease? Thorax 73(6), 565–574 (2018).
- 83. Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages. Exp. Mol. Med. 46(1), e70–e70 (2014).
- 84. Long-term expansion of human induced pluripotent stem cells in a microcarrier-based dynamic system. J. Chem. Technol. Biotechnol. 92(3), 492–503 (2017).
- 85. . Attachment and detachment strategies in microcarrier-based cell culture technology: a comprehensive review. Mater. Sci. Eng. C 103, 109782 (2019).
- 86. Enhanced in vivo function of bioartificial lungs in rats. Ann. Thorac. Surg. 92(3), 998–1006 (2011).
- 87. Engineering pulmonary vasculature in decellularized rat and human lungs. Nat. Biotechnol. 33(10), 1097–1102 (2015).
- 88. Transplantation of bioengineered rat lungs recellularized with endothelial and adipose-derived stromal cells. Sci. Rep. 7(1), 1–15 (2017).
- 89. Utilization of natural detergent potassium laurate for decellularization in lung bioengineering. Tissue Eng. – Part C Methods 25(8), 459–471 (2019).
- 90. A rapid lung de-cellularization protocol supports embryonic stem cell differentiation in vitro and following implantation. Tissue Eng. – Part C Methods 18(8), 632–646 (2012).
- 91. Epac agonist improves barrier function in iPSC-derived endothelial colony forming cells for whole organ tissue engineering. Biomaterials 200, 25–34 (2019).
- 92. . Lung microvascular niche, repair, and engineering. Front. Bioeng. Biotechnol. 8, 1–19 (2020).
- 93. Enhanced re-endothelialization of decellularized rat lungs. Tissue Eng. – Part C Methods 22(5), 439–450 (2016).